Table 3.
Comparison between predisposing conditions of erysipelas in the lower limbs
| |
Single episode |
Recurrent episode |
OR (95% CI) from univariable analysis |
p-value |
OR (95% CI) from multivariable analysis
1)
|
p-value |
|---|---|---|---|---|---|---|
| n = 231 (100%) | n = 111 (100%) | (95% CI) | (95% CI) | |||
| CABG |
11 (4.8) |
11 (9.7) |
2.2 (0.9-5.2) |
0.08 |
2.0 (0.8-5.1) |
0.12 |
| Skin disease |
26 (11.3) |
23 (20.7) |
2.1 (1.1-3.8) |
0.02 |
1.9 (1.0-3.7) |
0.05 |
| Severe obesity |
1 (0.4) |
4 (3.6) |
8.5 (0.9-77.9) |
0.06 |
4.6 (0.5-45.8) |
0.19 |
| Venous insufficiency |
14 (6.1) |
16 (14.4) |
2.6 (1.2-5.6) |
0.02 |
2.3 (1.0-5.2) |
0.05 |
| Lymphedema |
6 (2.6) |
9 (8.1) |
3.3 (1.1-9.5) |
0.03 |
4.3 (1.3-14.0) |
0.02 |
| Local wound |
118 (51.1) |
49 (44.1) |
0.8 (0.5-1.2) |
0.23 |
0.8 (0.5-1.3) |
0.42 |
| COPD |
15 (6.5) |
2 (1.8) |
0.3 (0.06-1.2) |
0.08 |
0.2 (0.04-1.0) |
0.05 |
| Diabetes mellitus |
44 (19.1) |
20 (18.0) |
0.9 (0.5-1.7) |
0.82 |
|
|
| Malignancy |
20 (8.7) |
14 (12.6) |
1.5 (0.7-3.1) |
0.29 |
|
|
| Toe web intertrigo |
10 (4.3) |
8 (7.2) |
1.7 (0.7-4.5) |
0.27 |
|
|
| Local operation2) | 49 (21.2) | 27 (24.3) | 1.2 (0.7-2.0) | 0.28 |
1)-Adjusted for all of the variables in the column; 2)-CABG included.